FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and can be used for determining the metastatic potential of invasive breast cancer. That is ensured by using a composition for staining histologic preparations of breast tumour tissue when determining a metastatic potential of invasive breast cancer which contains aqueous solutions of toluidine blue, alcian blue and Schiff's reagent containing Schiff's reagent. Concentrations of toluidine blue, alcian blue and Schiff's reagent are in the composition in ratio of 1/5/1. Also disclosed is a method for determining a metastatic potential of invasive breast cancer.
EFFECT: group of inventions enables to determine a metastatic potential of invasive breast cancer.
5 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINATION OF THE METASTATIC POTENTIAL OF BREAST | 2017 |
|
RU2646787C1 |
| METHOD FOR PREDICTION OF LYMPHATIC CANCER SPREAD ACCOMPANYING NON-SPECIFIC BREAST CARCINOMA | 2014 |
|
RU2566732C1 |
| METHOD FOR PREDICTING FIVE-YEAR SURVIVAL RATE IN PATIENTS WITH INFILTRATING BREAST CANCER BY DETERMINING TOTAL SCORE OF MALIGNANCY | 2013 |
|
RU2547561C1 |
| METHOD FOR PREDICTING LYMPHOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND | 2016 |
|
RU2659938C2 |
| METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS | 2015 |
|
RU2578462C1 |
| METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN DOUBLE-SIDED SYNCHRONOUS INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2015 |
|
RU2589287C1 |
| METHOD OF PREDICTING HEMATOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND BASED ON DETERMINATION OF DIFFERENT POPULATIONS OF CIRCULATING TUMOR CELLS IN BLOOD BEFORE TREATMENT | 2018 |
|
RU2678202C1 |
| METHOD FOR PREDICTION OF DEGREE OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH LUMINAL MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2632112C1 |
| METHOD FOR PREDICTION OF FULL REGRESSION PROBABILITY DURING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH THREE-TIMES NEGATIVE MOLECULAR-GENETIC SUBTYPE OF BREAST CANCER | 2016 |
|
RU2623118C1 |
| METHOD FOR PREDICTION OF HEMATOGENIC METASTASIS IN INVASIVE BREAST CARCINOMA OF NONSPECIFIC TYPE | 2019 |
|
RU2722274C1 |
